Skip to main content
. 2022 Jun 20:ciac496. doi: 10.1093/cid/ciac496

Figure 1.

Figure 1.

Comparison of antiviral activity (A) and neutralization (B) against BA.2 PRSD01 after nirmatrelvir combined with ritonavir recrudescence. Dose response curves, half-maximal inhibitory concentrations, and half-maximal authentic virus-neutralizing antibody concentrations show the averages ± standard deviation from 2 independent experiments with 2 biological replicates. Abbreviations: Ab, antibody; Ctl, control; IC50, half-maximal inhibitory concentration; NM/r, nirmatrelvir combined with ritonavir; NT50, half-maximal authentic virus-neutralizing antibody concentration.